Product Information
DROXIA 200 MG CAPSULE is a brand product labeled by H2-Pharma LLC, priced at $0.7291 per EA under NDC 61269040260. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
H2-Pharma LLCNDC
61269040260
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
HYDROXYUREAApproval Type
New Drug (NDA)
FDA Application
NDA016295FDA Approved
Before 1982
TE Code
AB
On Market Since
6/1/2009
Pharmacological Classes
Price Statistics
The NADAC for DROXIA 200 MG CAPSULE has been published 123 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7291 per EA |
|---|---|
| All-time high | $0.7318 (May 15, 2024) |
| All-time low | $0.7277 (Apr 23, 2025) |
| 52-week high | $0.7291 |
| 52-week low | $0.7291 |
| Median price | $0.7291 |
| Average price | $0.7293 |
| Largest weekly change | -0.5% (May 22, 2024) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the HYDROXYUREA market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DROXIA 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DROXIA 200 MG CAPSULE, manufactured by H2-Pharma LLC, is $0.7291 per EA (NDC 61269040260), effective Aug 19, 2026.
How has the price of DROXIA 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DROXIA 200 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for DROXIA 200 MG CAPSULE?
Since Apr 17, 2024, the NADAC for DROXIA 200 MG CAPSULE has ranged from a low of $0.7277 (Apr 23, 2025) to a high of $0.7318 (May 15, 2024), with a median of $0.7291 per EA.
Are there cheaper alternatives to DROXIA 200 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of DROXIA 200 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DROXIA 200 MG CAPSULE?
DROXIA 200 MG CAPSULE (NDC 61269040260) is labeled by H2-Pharma LLC, and CMS classifies it as a brand product.